Parasite egress from infected erythrocytes and invasion of new red blood cells are essential for the exponential asexual replication of the malaria parasite resulting in malaria pathology.
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expressed, tightly synchronized DPAP3-HA and DPAP3-mCh parasites were collected every 3h throughout the erythrocytic cycle and were either lysed and analyzed by WB ( Fig. 1e ), or fixed for immunofluorescence analysis (IFA, Figs. 1f and S1). Consistent with its transcription profile 23 , DPAP3 is most abundant in late schizonts and merozoites, but could also be detected in rings and trophozoites by WB. Although we could detect multiple processed forms of DPAP3 by WB, these processed forms are rarely observed in live parasites ( Fig. 1c ) and are likely an artefact of parasite lysis (see below).
By IFA, DPAP3 was first detected in young schizonts (6-8 nuclei) and seems to be expressed at the same time as rhoptry (RON4 and RopH2) and inner membrane complex (GAP45) proteins (Figs. 1f, S1 and S2). During schizont maturation, DPAP3 and rhoptry proteins localization changes from a diffuse and granular cytosolic staining to a clear punctuated apical staining in daughter merozoites (Figs. 1f-g, S1 and S2), probably reflecting protein trafficking and organelle biogenesis. By contrast, exonemal (SUB1) and micronemal proteins (AMA1) are expressed and localize to their apical organelles at a later stage (Figs. 1f and S2).
Using standard confocal microscopy, we could not observe consistent colocalization of DPAP3
with any apical organelle marker tested. We therefore decided to increase the resolution of our images by using structured illumination microscopy (SIM). By SIM we could clearly observe DPAP3 staining in small but well-defined dot-like structures at the apical pole of each merozoite in the DPAP3-HA (Figs. 1h and S3a) and DPAP3-GFP ( Fig. S3b ) lines. Although we did not observe colocalization with exoneme (SUB1), microneme (EBA175) or rhoptry (RON4, RopH2) protein markers (Figs. 1h and S3), DPAP3 seems to be closely associated with RON4, suggesting that it resides in apical organelles that surround the neck of the rhoptries (Fig. 1h ).
PfDPAP3 is secreted after PVM breakdown. Timely discharge of proteins from the different apical organelles is crucial to regulate parasite egress and RBC invasion 24 . Secretion of exonemal and micronemal proteins is mediated through activation of cGMP-dependent protein kinase G (PKG), which takes places 15-20 min before egress 9 . Release of SUB1 into the PV leads to parasite egress. Secretion of micronemal adhesin proteins, such as AMA1 or EBA175, onto the parasite surface is essential for merozoite attachment to the RBCM and invasion. To determine whether DPAP3 is secreted, we compared the level of DPAP3 present within parasites, in the PV and RBC cytosol (collected after saponin lysis), and secreted in the DPAP3 role in RBC invasion. 5 culture supernatant at three different stages of egress: schizonts arrested before exoneme/microneme secretion with the PKG reversible inhibitor compound 2 (C2), schizonts arrested between PVM and RBCM breakdown using the general cysteine protease inhibitor E64, and free merozoites collected after egress. In E64-arrested schizonts the erythrocyte is still intact but the RBCM is highly porated allowing leakage of RBC and PV proteins 25 . Parasite pellets, PV and RBC cytosol proteins, and proteins secreted in the culture supernatant under these three conditions were collected after treating our cultures with the fluorescent activitybased probe FY01 26 in the presence or absence of the DPAP3 covalent inhibitor SAK1. FY01 is cell-permeable probe that covalently modifies the catalytic Cys of DPAP3 17 . Fluorescently labelled DPAP3 can then be visualized by in-gel fluorescence in an SDS-PAGE gel. Pretreatment of parasites with SAK1 prevents probe labelling resulting in the loss of the DPAP3 fluorescent band ( Fig. 2a ). Note that E64 does not inhibit DPAP3 since it does not block FY01 labelling. DPAP3 was detected in the culture supernatant and saponin fraction of E64arrested or rupturing schizonts but not of C2-treated parasites, indicating that it is secreted downstream of PKG activation but before merozoites become extracellular. The presence of DPAP3 in E64-arrested schizont pellets and free merozoites suggests only partial secretion before egress. DPAP3 secretion was confirmed by WB on the DPAP3-HA line and was only detected in the culture supernatant in the absence of C2 (Fig. 2b) .
To determine the timing of DPAP3 secretion, DPAP3-mCh schizonts were arrested with C2 and parasite egress monitored by live microscopy after C2 wash out. Using this assay, PVM breakdown is clearly observable on the DIC channel when merozoites become more spread out within the RBC and their shape is better defined 12, 25 . This is followed by RBCM rupture and merozoites dispersal ( Fig. 2c and Video S1). Quantification of fluorescence signal in these egress video shows a 40% decrease in mCherry signal right after PVM breakdown but before RBCM rupture (Fig. 2d ). Interestingly, cKO of SUB1 has recently been shown to prevent breakdown of the PVM but not secretion of micronemal AMA1 into the merozoite surface 9 (Michael Blackman personal communication). This suggests that DPAP3 secretion occurs downstream of exoneme and microneme secretion and might be triggered by PVM breakdown.
To confirm that DPAP3 is secreted into the RBC cytosol after PVM breakdown, we performed immuno electron microscopy (IEM) on DPAP3-GFP schizonts collected at the time of egress DPAP3 role in RBC invasion. 6 ( Fig. 2e ). In schizonts containing an intact PVM, DPAP3-GFP staining was observed at the apical end of merozoites, and in some sections in close proximity to the rhoptries or enclosed within membrane bound vesicles, thus confirming our IFA results. In IEM images collected on schizonts after PVM breakdown a high number of immuno staining was observed in the RBC cytosol. Rarely any DPAP3 staining was detected in the PV of schizonts with an intact PVM.
Removal of the prodomain is not required for DPAP3 activation. DPAPs are composed of a signal peptide, an exclusion domain, a prodomain, and a C-terminal catalytic domain.
Processing of DPAPs has mainly been studied for the mammalian homologue cathepsin C (CatC) and starts with removal of the signal peptide in the ER upstream of the exclusion domain N-terminal aspartate. This residue is critical for activity as it directly interacts with the free N-terminal amine of DPAP substrates 18 . Further processing consists of removal of the inhibitory prodomain and cleavage of the catalytic domain downstream of the catalytic Cys, which for CatC has been shown to be mediated by lysosomal cysteine cathepsins ( Fig. 3a) .
Thus, each DPAP proteolytic unit is generally composed of three oligopeptides (exclusion domain and the N-and C-terminal portions of the catalytic domain), and CatC is composed of four proteolytic units 27 . Although Plasmodium DPAP1 seems to be processed in a similar way 28 , its final form is composed of a single proteolytic unit, thus showing that tetramerization is not required for DPAP activity (Fig. 3a ).
Three different isoforms of DPAP3 consistent with the canonical processing of DPAPs were previously shown to be labelled by FY01 in merozoite lysates under acidic conditions 17 (120, 95, and 42kDa forms). However, when intact schizonts or merozoites are directly boiled in SDS-PAGE loading buffer, we predominantly detect the p120 form either by WB or FY01 labelling (Figs. 1-2), suggesting that DPAP3 processing might be an artefact of parasite lysis.
To confirm this, we show that incubation of merozoite lysates under acidic conditions results in a time-dependent processing of DPAP3, which was not observed at neutral pH ( Fig. 3b ).
Although FY01-labelling of the p120 'zymogen' form indicates that its active site is accessible and contains a nucleophilic cysteine, it does not demonstrate that it can turnover substrates.
To address this point, we expressed full-length DPAP3 in insect cells using the baculovirus system 29 . Recombinant expression and purification of DPAP3 from the insect cells culture supernatant yielded predominantly the p120 and p95 forms ( Fig. 3c ), which are able to cleave DPAP3 role in RBC invasion. 7 the VR-ACC fluorogenic DPAP substrate 30 (Fig. 3d ). The detection of a 40kDa band by WB using an anti-DPAP3-Ct suggests that cleavage of p120 DPAP3 into the p95 form occurs downstream of the catalytic Cys ( Fig. 3c ). However, given their molecular weights, both forms must contain the prodomain, indicating that its removal is not required for DPAP3 activation.
Finally, we show that mutation of the catalytic Cys to Ser completely inactivates DPAP3 ( Fig. 3d ). This inactive C504S mutant was used as a negative control in our complementation studies (see below).
In one of our purifications we were able to separate the p120 form from a fraction containing a mixture of the p95 and p120 forms ( Fig. 3e ). Although DPAP3 was more abundant in the latter fraction, when VR-ACC turnover was normalized to the total amount of FY01 labelling (i.e. p120+p95 labelling), both fractions showed identical Vmax and Km values, suggesting that these two forms are equally active and that removal of the signal peptide is sufficient to activate DPAP3. Finally, we show that DPAP3 is active under mild acidic conditions, with an optimal pH of 6 ( Fig. 3f ). The facts that the p120 form of recombinant DPAP3 is active and that this is the predominant form found in live parasites strongly suggest signal peptide removal is sufficient to activate DPAP3, and that this "zymogen" form is the one performing a biological function in parasites.
Generation of DPAP3 cKO and complementation lines.
Since we were unable to directly KO DPAP3, we generated DPAP3 cKO lines on the 1G5 parasite line background that endogenously expressed DiCre 31 . In the DiCre system, Cre recombinase is split into two domains fused to rapamycin (RAP) binding domains. Addition of RAP triggers dimerization and activation of DiCre, leading to rapid recombination of specific DNA sequences known as LoxP sites 32, 33 . We used this system to conditionally truncate the catalytic domain of DPAP3 rather than excising the full gene to prevent potential episomal expression of DPAP3 after excision.
Two independent strategies that differ in how the LoxP site was introduced within the dpap3 open reading frame (ORF) were used in this study (Fig. 4a ). In both cases, a LoxP site was introduced downstream of the 3'-UTR. The other was inserted either within an Asn-rich region of DPAP3 predicted not to interfere with folding or catalysis, or within an artificial intron (LoxPint), which does not alter the ORF of the targeted gene and that has been shown DPAP3 role in RBC invasion. 8 to be well tolerated in several P. falciparum genes 12, 34, 35 . In both instances, the recodonized catalytic domain was tagged with mCherry such that RAP-induced truncation would result in the loss of mCherry signal. A control line containing only the 3'-UTR LoxP site was also generated. After transfection of 1G5 parasites, drug selection, and cloning, three DPAP3cKO clones (F3cKO and F8cKO with loxPint, and A1cKO with loxP in Asn-stretch), and the E7ctr line (only one loxP) were selected for further studies. Evidence of integration by PCR is shown on Fig. S4b . Analysis of genomic DNA of DMSO-or RAP-treated cKO lines by PCR showed highly efficient excision ( Fig. 4b ) resulting in the loss of DPAP3-mCh expression in mature schizonts ( Fig. 4c-d ). Although we consistently achieved more than 95-99% excision efficiency ( Fig. 4e ), a fraction of non-excised parasites was always present after RAP treatment, which explains the presence of a pre-excision DNA band by PCR after RAP treatment ( Fig. 4b ).
To confirm that any phenotypic effect observed upon conditional truncation of DPAP3 is due to the loss of DPAP3 activity, A1cKO and F8cKO parasites were transfected with plasmid expressing WT or MUT DPAP3-HA under the control of the dpap3 or ama1 promoters ( Fig.   S4a ), resulting in the following complementation lines: F8cKO+WTdpap3, F8cKO+MUTdpap3, F8cKO+WTama1, F8cKO+MUTama1, A1cKO+WTdpap3, A1cKO+WTama1, A1cKO+MUTama1. All complementation lines grew normally before RAP treatment and showed no delay in intracellular parasite development.
IFA analysis confirmed colocalization between chromosomal DPAP3-mCh and episomal
DPAP3-HA ( Fig. 4f ). Episomal expression could only be detected in 70-80% of schizonts independently of RAP treatment, probably due to different levels of episomal expression and plasmid segregation in schizonts ( Fig. 4g ). Efficient but not complete truncation of DPAP3-mCh was observed in all our complementation lines ( Fig. 4e ). Labelling of DPAP3 with FY01 in parasite lysates from these lines show clear labelling of chromosomal DPAP3-mCh and episomal WT DPAP3-HA but not MUT DPAP3-HA ( Fig. 4h ). As expected, RAP treatment results in a decrease of labelling of chromosomal DPAP3-mCh but not of episomal WT DPAP3-
HA.
Conditional knock out of DPAP3 reduces viability of blood stage parasites. To measure the effect of DPAP3 truncation on parasite replication, we used the recently published plaque DPAP3 role in RBC invasion. 9 assay 16 where the wells of a 96-well flat bottom plate containing a thin layer of blood were seeded with ~10 iRBCs/well. After 10-14 days, microscopic plaques resulting from RBC lysis can be detected. RAP treatment of our cKO lines resulted in 90% less plaques, an effect that could be partially rescued through episomal complementation with WT but not MUT DPAP3 ( Fig. 5a , Table S1 ). After RAP treatment of the F3cKO and F8cKO line some wells contained a single plaque, suggesting that only one clonal parasite population grew in that well. Parasites present in 12 of these wells were propagated and dpap3 excision checked by PCR. All contained non-excised parasites but dpap3 excision was detected in three cultures (Fig. 5b) .
The presence of excised parasites in some of the wells suggests that DPAP3KO parasites replicate less efficiently and might not have had enough time to form a microscopic plaque within the 14 days of the assay. That said, the presence of non-excised parasites on all samples indicates that WT parasites quickly outcompeted DPAP3KO ones.
To test this hypothesis, we perform standard parasite replication assays after RAP or DMSO treatment. To prevent parasite overgrowth, cultures were diluted 10-fold in fresh blood and media whenever parasitemia reached 5%. RAP treatment of DPAP3cKO parasites results in a 10-to 15-fold decrease in parasitemia after 3-4 cycles, corresponding to an overall 50% decrease in multiplication rate per cycle compared to DMSO treatment ( Fig. 5c ). However, these values likely underestimated the importance of DPAP3 on parasite replication since 5 cycles after RAP treatment 60% of parasites are non-excised and express DPAP3-mCh ( Fig. S4a ), thus proving that the small fraction of non-excised parasites quickly outcompete the excised ones. After RAP treatment, parasites complemented with WT DPAP3 grew significantly faster than those complemented with MUT DPAP3 (Fig. 5d ). Importantly, our multiple attempts to clone DPAP3KO parasites after RAP treatment failed, indicating that DPAP3 activity is required for parasite propagation under our culturing conditions.
To determine which point of the erythrocytic cycle is disrupted by the loss of DPAP3, a tightly synchronized culture of A1cKO parasites at ring stage was treated with DMSO or RAP for 3h, and the culture was monitored for the following 80h. Samples were collected every 2-4h, stained with Hoechst, and analyzed by FACS. No significant difference in DNA staining was observed between WT and KO parasites suggesting that DPAP3 is not required for intracellular development (Fig. 5e , left graph). Quantification of iRBCs belonging to the first or second cycle after treatment shows that DPAP3KO parasites egress at the same time as WT DPAP3 role in RBC invasion. 10 but produce ~50% less rings ( Fig. 5e , right graph). This suggests that DPAP3 is only important for efficient RBC invasion, which is in direct contradiction with its previously suggested role in egress 17 .
PfDPAP3 does not play a role in parasite egress. Despite being expressed early during schizogony ( Fig. 1f ), we did not observe any delay in schizogony ( Fig. 5e ). This was confirmed by IFA by counting the number of mature schizonts at the end of the cycle after excision.
Apical localization of SUB1 to the exonemes was used as a marker for schizont maturity Previously published work using the SAK1 inhibitor showed arrest of egress upstream of SUB1 activation 17 . The data suggested that DPAP3 might be important for parasite egress.
Although we have been able to reproduce these results, we show that SAK1 treatment of schizonts 6h before egress arrests schizogony upstream of SUB1 and AMA1 protein expression rather than parasite egress ( Fig. S6 ), which explains why no SUB1 or AMA1 could be detected by WB in the previous study 17 . In addition to SAK1, we also synthesized a more selective inhibitor by replacing the nitro-tyrosine P2 residue of SAK1 with L-Trp (L-WSAK) and a diastereomer negative control containing D-Trp in P2 (D-WSAK). To test the specificity of these inhibitors, merozoite or schizont lysates were pre-incubated with a dose response of compound followed by 1h labelling with 1µM FY01 (Fig. 6a ). Although SAK1 blocks labelling of DPAP3 at lower concentration than L-WSAK, it also inhibits all the falcipains above 5µM, while L-WSAK only inhibits other targets above 200µM. As expected, the D-WSAK control is unable to inhibit any of the labelled cysteine proteases and is at least 100-fold less potent than L-WSAK at inhibiting DPAP3 ( Fig. 6a ). We then compared the effect of these inibitors in parasite egress in the A1cKO line. Surprisingly, all blocked egress independently of RAP treatment (Fig. 6b ), and no difference in potency between L-and D-WSAK was observed. This results prove that these vinyl sulfone inhibitors do not act through inhibition of DPAP3 but rather through off-target or toxic effects.
As a final proof to show that DPAP3 is not involved in parasite egress, we arrested DMSO or RAP treated F8cKO schizonts with C2 and monitored egress by live microscopy after removal DPAP3 role in RBC invasion.
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of the PKG inhibitor. Analysis of these videos showed no significant difference in the number of schizonts that ruptured, nor on how fast merozoites egressed after C2 wash out ( Fig. 6c , Video S2). Also, we could not detect differences in the levels and/or processing of AMA1 36 and SUB1 substrates (SERA5 10 and MSP1 13 ) between DMSO and RAP treated parasites ( Fig. 6d ).
These findings together with the lack of colocalization between DPAP3 and SUB1 (Figs. 1h and S3) clearly demonstrate that DPAP3 is not responsible for proper processing and activation of SUB1, and that DPAP3 does not play a role in egress. However, its localization in an apical secretory organelle (Figs. 1-2) and the time-course analysis of the A1cKO line ( Fig. 5e ) strongly suggest a function in RBC invasion.
PfDPAP3 is important for efficient attachment of merozoites to the surface of RBCs.
Mature schizonts obtained after DMSO or RAP treatment of our different parasite lines were incubated with fresh RBCs for 8-14 h, fixed, and the population of schizonts and rings quantified by FACS ( Fig. 7a ). On average, we observed a 50% reduction in the number of infected erythrocytes after RAP treatment of our cKO lines ( Fig. 7b ). This invasion defect could be rescued by episomal expression of WT but not MUT DPAP3 independently of the promoter used (ama1 or dpap3), indicating that DPAP3 activity is important for RBC invasion ( Fig. 7b ).
To determine which invasion step is impaired by the loss of DPAP3, DMSO-or RAP-treated cKO parasites were arrested at schizont stage with C2, incubated with fresh RBCs after C2 washout, and samples collected at different time points for FACS analysis. Fluorescent wheat germ agglutinin (WGA-Alexa647) binds to lectins on the RBC surface and when combined with Hoechst staining allows us to differentiate free merozoites from iRBCs ( Fig. 7c) .
Quantification of the different parasite stage populations over time clearly shows a decrease in the number of rings upon RAP treatment, with an inversely proportional to an increase in the number of free merozoites (Figs. 7c and S7).
The RBC population showing similar levels of DNA signal as free merozoites is mainly composed of ring stage parasites but likely contain a proportion of extracellular merozoites attached to the surface of the erythrocyte. These two populations were differentiated by staining the samples with an MSP1 antibody since MSP1 is shed during RBC invasion ( Fig. 7d ).
Using this assay, we did not observe a significant difference in the number of attached DPAP3 role in RBC invasion.
merozoites relative to the number of rings between DMSO and RAP treatment of cKO lines.
This suggests that after DPAP3KO parasites tightly attach to the RBC surface they invade as efficiently as WT parasites, and that DPAP3 is likely important for the initial recognition of the RBC.
Discussion
This study provides the first characterization of the biological function of DPAP3 in parasite development. We have shown that DPAP3 is critical for efficient RBC invasion and parasite replication, that it is expressed early during schizogony and localizes to small apical organelles that are closely associated with the neck of the rhoptries, and that DPAP3 is secreted after PVM breakdown but before parasite egress. We have also demonstrated that DPAP3 has dipeptidyl aminopeptidase activity but contrary to other DPAPs, removal of the prodomain is not required for its activation. Our cKO and complementation studies provide strong evidence that DPAP3 activity is only require for efficient RBC invasion, but that it is not required for intracellular parasite development or parasite egress. Finally, our initial characterization of the invasion defect associated with the loss of DPAP3 suggests that this protease plays an important role in the initial attachment of merozoites to the RBC surface.
The fact that DPAP3 is expressed early during schizogony, that it localizes in secretory organelles, and that it is active under mild acidic conditions suggest that DPAP3 might process its substrates before it is secreted. It is difficult to speculate about the nature of these substrates since we could not colocalize DPAP3 with any of the tested apical markers. That said, DPAP3 might process transmembrane or GPI-anchored substrates residing within the same apical organelle but relocalizing to the merozoite surface after secretion (similarly to micronemal and some rhoptry proteins 8 ). Alternatively, DPAP3 might reside in an apical late endosome compartment and might be important for sorting secretory proteins to their correct apical organelles by selective trimming their N-termini after signal peptide removal.
Indeed, the N-terminal sequence downstream of the signal peptide has been shown to be important for proper localization of rhoptry and micronemal proteins both in P. falciparum 37, 38 and T. gondii 39, 40 . Micronemes are believed to be trafficked to the merozoites apex underneath the IMC before releasing their protein content, thus coming in very close proximity to the neck of the rhoptries 41, 42 . It is however unclear whether micronemes fuse DPAP3 role in RBC invasion. 13 with the plasma membrane or the neck of the rhoptries to release their cargo. Therefore, DPAP3 might get in contact with proteins from other secretory organelles at the time of secretion, similarly to how micronemal CyRPA and PfRipr come together with rhoptry PfRh5 at the merozoite apex after egress 43 . At this stage, we cannot discard the possibilities that DPAP3 might process its substrates after secretion or during trafficking (in the ER or Golgi) since DPAP3 is continuously expressed from early schizogony until egress. The fact that DPAP3 is active under mild acidic condition and that is labelled FY01 at pH 7.2 ( Fig. 3 ), suggest it might be able to cleave its natural substrate a neutral pH. However, we think it is unlikely that DPAP3 acts extracellularly on RBC surface proteins because co-culturing equal amounts of WT and DPAP3KO parasites did not recued the DPAP3KO invasion defect (data not shown).
We hypothesize that DPAP3 processes the N-terminus of adhesin proteins on the merozoite surface, either during traffic or after secretion, thus changing their affinity toward RBCM receptors. Most merozoite surface proteins are processed during traffic or after secretion, thus exposing one or multiple extracellular free N-termini that might be potential DPAP3 substrates 7, 44 . These include most, if not all, type I transmembrane surface proteins, which expose their N-terminal ectodomain (EBAs, Rhs, etc), GPI-anchored proteins (MSP1, SUB2, P113), and surface proteins interacting with membrane-anchored protein (Rh5, Ripr, MSP6&7). To the best of our knowledge the specific functions of these N-terminal residues have not been studied, however the N-terminal region of some of these proteins has been shown to be key in mediating protein-protein interactions important for RBC invasion. These include interaction between GPI-anchored P113 and the N-terminal of Rh5 45 , between the Nterminal domain of PfRh4 and host CR1 46 , or between the N-terminal of AMA1 and RON2.
Also, conformational changes of the N-terminal tail of micronemal PfTRAP and TgMIC2 have been shown to be important for invasion of hepatocytes by Plasmodium sporozoites, and for motility of the related Apicomplexan parasite Toxoplasma gondii, respectively 47, 48 .
Interestingly, T. gondii also expresses DPAPs in secretory organelles 49 , and a recent proteomic study has shown evidence that the N-terminus of certain secreted proteins, such as TgSUB1, TgMIC11, and TgSUB1, might be trimmed through the removal of dipeptides 50 . It is therefore possible that DPAP3-mediated trimming of the N-terminus of certain merozoite surface proteins might modulate the function of adhesin factors. Interestingly, during our invasion assays we observed a lot of variation in the effect of DPAP3 KO on RBC invasion, ranging from DPAP3 role in RBC invasion. 14 25-75% inhibition (Fig. 7a ). We think this variation might reflect heterogeneity among the different batches of blood used to perform invasion assays and suggests that DPAP3 activity might be important to recognize specific RBCM receptors that are differentially expressed in the human population.
Finally, our studies show that DPAP3 is an unusual papain-fold protease since removal of its prodomain is not required for activation. Most proteases prodomains act as endogenous inhibitors and internal chaperones. Although the prodomain of DPAP3 might be required for proper folding of this large protein (941aa), we cannot discard the possibility that it might have other biochemical functions, such as recognising substrates or binding to cofactors that modulate DPAP3 activity. Interestingly, the pro-form of P. falciparum DPAP1 has been shown to localize to the PV in mature schizonts 28 , and we have been able to consistently label it with FY01, suggesting that similarly to DPAP3, its 'zymogen' form might be active and able to process the N-terminus of merozoite surface proteins. Thus, DPAP1 and DPAP3 might play redundant or complementary functions during RBC invasion, and further genetic and inhibitor studies are required to determine whether inhibitors with dual specificity would completely block RBC invasion.
Methods
Synthesis of inhibitors, production of DPAP3 antibodies, and a list of primers (Table S2) and antibodies (Table S3 ) used in this study are shown in the supplementary methods. 
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HA was replace with mCh-amplified from the pREST-B plasmid 51 -to generate the pHH1-SERA5ΔCt-mCh, and the ORF of WT or MUT DPAP3 introduced into this plasmid to generate the pHH1-chDPAP3-wt/mut-mCh constructs.
To conditionally truncate dpap3 we used two different approaches. The first approach introduced a loxP site within the ORF of dpap3, in an Asn-rich region (Asn414-Asn444) upstream of the catalytic domain, resulting in replacement of Asn430-Asp434 with a loxP coding peptide (ITSYSIHYTKLFTG). To make the pHH1-chDPAP3_loxP-mCh construct (Fig.   S8c ), the N-and C-terminal portions of DPAP3 were amplified from the pHH1-chDPAP3-wt-mCh, which contains a 3'UTR LoxP site, and ligated into the plasmid backbone. A LoxP site was introduced in the backward primer used to amplified the N-terminal region. The second approach inserted a loxPint 34 between the homology and recodonized regions. A synthetic 1600bp sequence (GeneWiz®) containing the loxPint fragment flanked by targeting sequences was introduced into construct pHH1-chDPAP3-wt-mCh to generate the pHH1-chDPAP3_loxPint-mCh plasmid.
Finally, for episomal complementation of the cKO lines, plasmids pHH1-chDPAP3-wt/mut-HA ( Fig. S8a) were modified in order to express full-length WT or MUT DPAP3 under the control of the dpap3 or ama1 promoters. Firstly, to select for parasites containing the complementation plasmids after transfection, the puromycin N-acetyltransferase (pac) gene, which confers resistance to puromycin, was amplified from mPAC-TK (a kind gift of Alex Maier) and subsequently ligated into pHH1-chDPAP3-wt/mut-HA plasmids. The homology region of this plasmid was replaced with a recodonized N-terminal dpap3 amplified from puc57-rDPAP3-Nt, resulting in pHH1-rDPAP3-wt/mut-HA plasmids (Fig. S8c) . The dpap3 and ama1 promoters (970 and 1456bp upstream of the start codon, respectively) were amplified from genomic DNA and ligated into these plasmids to generate the pHH1-dpap3-rDPAP3wt/mut-HA, and pHH1-ama1-rDPAP3-wt/mut-HA complementation constructs.
All final construct sequences were verified by nucleotide sequencing on both strands. Primers for PCR amplification and restriction sites used to generate these plasmids are indicated in Fig. S8 and listed in Table S2 .
Generation and maintenance of transgenic parasite lines. All constructs were transfected DPAP3 role in RBC invasion.
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at schizont stage using a 4D-Nucleofector electroporator (Lonza) as previously described 12 .
DPAP3-tagged and DPAP3-cKO lines were obtained through multiple on and off drug selection cycles with WR99210 (Jacobus Pharmaceuticals) and cloned by limited dilution as previously described 52 . To generate the DPAP3-GFP, DPAP3-HA and DPAP3-mCh lines, pPM2GT-DPAP3Ct-GFP, pHH1-chDPAP3-wt-HA and pHH1-chDPAP3-wt-mCh were transfected into P. falciparum 3D7 parasites. Plasmid pHH1-chDPAP3-mut-mCh was transfected multiple times into 3D7 in an attempt to swap the endogenous catalytic domain of DPAP3 with one containing the inactivating C504S mutation, but no integration was observed even after five drug cycles. The A1cKO, F3cKO & F8cKO lines were obtained after transfection of pHH1-chDPAP3_loxP-mCh and pHH1-chDPAP3_loxPint-mCh, respectively, into P. falciparum 1G5 parasites that endogenously expressed DiCre. Finally, the E7ctr line containing only the 3'UTR loxP site was generated by transfecting 1G5 parasites with pHH1-chDPAP3-wt-mCh.
Complementation lines were obtained after transfection of A1cKO or F8cKO with pHH1-dpap3-rDPAP3-wt-HA, pHH1-dpap3-rDPAP3-mut-HA, pHH1-ama1-rDPAP3-wt-HA, or pHH1-ama1-rDPAP3-wt-HA and selection with WR99210 and puromycin. All parasite lines were maintained in RPMI 1640 medium with Albumax (Invitrogen) containing WR99210 (plus puromycin for the complementation lines) and synchronized using standard procedures 53 .
To conditionally truncate the catalytic domain of DPAP3 tightly synchronized ring-stage parasites were treated for 3-4h with 100nM RAP (Sigma) or DMSO at 37°C, washed with RPMI, and returned to culture 9 . Schizonts purified at the end of the cycle were used to determine the excision efficiency at the DNA (PCR) or protein (IFA, WB) level.
Staining and microscopy. Thin films of P. falciparum cultures were air-dried, fixed in 4% (w/v) formaldehyde (PFA) for 20min (Agar Scientific Ltd.), permeabilized for 10min in 0.1%
(w/v) Triton X100 and blocked overnight in 3% (w/v) bovine serum albumin (BSA) or 10%
(w/v) goat serum (Invitrogen) in PBS. Slides were probed with monoclonal antibodies or polyclonal sera as described previously 54 (See Table S3 for antibodies used in this study), subsequently stained with Alexa488-, Alexa594-, Alexa647-labelled secondary antibodies Plaque assays. Plaque assays were performed as previously described 16 For standard invasion assays, schizonts purified from DMSO or RAP treated cultures were incubated with fresh RBCs for 8-14h, fixed, and stained with Hoechst. The population of uRBC, rings and schizonts was quantified based on DNA content. The invasion rate was determined as the ratio between the final population of rings and the initial population of schizonts.
Invasion time courses were performed by arresting purified schizonts with 1µM C2 for 4h, washing twice with warm media, and culturing with fresh RBCs under shaking conditions. Samples were collected at different time points, fixed, and split into two aliquots: One was stained with Hoechst and WGA-Alexa647 and run on a flow cytometer at a high forward scattering voltage in order to detect free merozoites. The populations of uninfected RBC (uRBC), free merozoites, rings, and schizonts were quantified from these data. The other aliquot was blocked with 3% BSA in PBS overnight at 4°C, and stained without permeabilization with the MSP1 monoclonal antibody 89.1 (1:100), and subsequently with anti-mouse Alexa488 (1:3000). The population of uRBC, schizonts, rings, and merozoites attached to the RBC surface were quantified using FlowJo.
Live microscopy imaging of egress and DPAP3 secretion. Time lapse video microscopy of
egress was performed as previously described 9 . Briefly tightly synchronized schizonts were percoll-enriched and arrested with 1µM C2 for 4h. After C2 wash out, DIC and mCherry images were collected every 5 and 25s, respectively, for 30min using a Nikon Eclipse Ni-E wide field microscope fitted with a Hamamatsu C11440 digital camera and a Nikon N Plan Apo λ 100x/1.45NA oil immersion objective. For each experiment, videos of the RAP-and DPAP3 role in RBC invasion.
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DMSO-treated parasites were taken alternately to ensure that differences in the rate of egress were not a result of variation in the maturity of the parasite populations. The images were then annotated using Axiovision 3.1 software and exported as AVI movie or TIFF files.
Individual egress events were annotated by detailed visual analysis of the movies, and the delay to the time of egress was recorded for each schizont for subsequent statistical analysis.
Mean fluorescence intensity values of individual mCherry-expressing schizonts right before and after PVM breakdown were determined from exported raw image files (TIFF format) as described previously 9 Table S3 for antibodies used in this study), and followed by application of horseradish peroxidase-conjugated secondary antibodies (Pierce).
The signal was detected using SuperSignal West Pico chemiluminescent substrate (Thermo Scientific) and a ChemiDoc MP imager (BioRad). Diagnostic PCR. PCR was performed using GoTag (Promega), Advantage 2 (Clontech), or Q5 High-Fidelity (NEB) polymerases. Diagnostic PCR to detect integration of targeting constructs was performed using extracted genomic DNA as template. Primer pairs specific for detection of integration, namely P21 and P22 for integration of pHH1-chDPAP3-mCh and pHH1-chDPAP3-HA, and II-inte_F and II-wt_R for pPM2GT-DPAP3Ct-GFP, were designed such that the forward primer hybridized in a genomic region upstream of the plasmid homology region, and the second in a region unique to the introduced plasmid. Primer pairs P21 and P23 were designed to detect presence of the unmodified dpap3 locus. To assess whether dpap3-mCh had been excised after RAP treatment, diagnostic PCR was performed using extracted genomic DNA as template. Primers P24 and M13 were used to detect non-excision dpap3 at the genomic locus and hybridize upstream and downstream of the second loxP site, respectively. Primers P25 and SP6 were used to detect presence of excision and hybridize DPAP3 role in RBC invasion.
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upstream and downstream of the first and second loxP sites, respectively. Figure 1. DPAP3 is expressed during schizogony and localizes at the apical pole. (a) Scheme showing the dpap3 endogenous locus (exons in grey, intron in pink) and how it was targeted by single homologous recombination with plasmids containing a homology region (blue line) followed by a recodonized C-terminal region (sc) tagged with HA3 or mCherry. The strategy to generate the DPAP3-GFP line is shown in Fig. S8 . The recodonized region contained either WT Cys504 or the C504S inactivating mutations. Plasmids also contained the hdhfr drug resistant cassette (black). (b) Integration efficiency at the dpap3locus assessed by PCR on genomic DNA using the P21 forward primer (black arrow) and the P22 (orange arrows) or P23 (blue arrow) backward primers for the endogenous or modified DPAP3 role in RBC invasion. Quantification of the population of attached merozoites relative to the ring population is shown on the bar graph between DMSO and RAP treatment of cKO lines. Each circle represents a different biological replicate, filled for A1cKO and empty for F8cKO. To significant difference was observed between DMSO and RAP treated parasites.
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